Featured Commentary
| Attention Deficit/Hyperactivity Disorder (ADHD) is a neurobehavioral developmental disorder that affects between 8-10 million adult Americans. Treatment strategies often involve a combination of medication, lifestyle and behavioral modification, and counseling. Though many psychotherapeutic modalities may be employed as alternatives or supplements to medication, Cognitive Behavioral Therapy (CBT) has demonstrated the most efficacy and is the most strongly supported by the current evidence base. Research has shown that a treatment program combining pharmaceutical and behavioral therapy may be the most effective ADHD management strategy. Cognitive-Behavioral Therapy for Adult ADHD: An Integrative Psychosocial and Medical Approach provides an overview of etiology, diagnosis, and comorbidity as well as treatment issues for adult ADHD. The authors discuss the multifactorial approach to treatment, relapse prevention, and long-term management of adult ADHD. |  SEE ALSO |
 | Cognitive Behavior Therapy Can Minimize Negative Thoughts in Adult ADHD J. Russell Ramsay, PhD |
 | Managing Relapses is Key to Managing Adult ADHD J. Russell Ramsay, PhD |
 | Time Management Techniques Can Help Adult ADHD Patients Combat Procrastination J. Russell Ramsay, PhD |
 | Case study of an adult patient with ADHD Anthony Rostain, MD |
 | Making a firm diagnosis and developing a treatment plan for adults with ADHD Anthony Rostain, MD |
 | Presentation and assessment of the patient with ADHD Anthony Rostain, MD |
 | The etiology and symptomatology of adult ADHD Anthony Rostain, MD |
Clinician.com Links
Major depressive disorder (MDD) is a leading cause of disability and premature mortality, but it remains underdiagnosed and undertreated. Effective screening, early diagnosis, and appropriate treatment can greatly mitigate the harmful and debilitating effects of this chronic psychiatric disorder. However, evidence suggests that management of depression is challenging for primary care providers (PCPs). First, PCPs must recognize and treat a wide range of manifestations in diverse populations. Second, it may be difficult to communicate the diagnosis of MDD to patients in a manner that promotes acceptance. Finally, selecting appropriate treatment from various psychosocial and pharmacologic options can be a formidable task. To ensure that an individualized patient-centered treatment plan is formulated, PCPs should remain knowledgeable about the clinical profiles of available agents. Importantly, they must implement treatment and monitoring strategies to achieve remission and full functional recovery in patients. This activity presents a comprehensive overview of best practices in screening, diagnosis, and treatment of MDD.